• Lipase, Serum
  • Coagulation Factor XI Activity Assay, Plasma
  • Microsomal epoxide hydrolase 1 (EPHX1) Gene Variation
  • AFF2 (AF4/FMR2 family, member 2) Gene Mutation Analysis
  • 17-Ketosteroids, Urine
  • Tumor Necrosis Factor Alpha (TNF-α)
  • Coccidioides Antibody, IgG
  • Fungitell® ß-D Glucan, CSF
  • Digoxin, Total, Serum
  • Cytochrome P450 3A5 (CYP3A5) Genotyping
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Legius Syndrome (SPRED1) Sequencing
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Legius Syndrome (SPRED1) Sequencing
Medical Test

Turnaround Time
Access to Legius Syndrome (SPRED1) Sequencing is restricted.